 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP  Get Free Report)s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of...

Oramed Pharmaceuticals (NASDAQ:ORMP) Shares Cross Below 200-Day Moving Average of $3.09

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP  Get Free Report)s share price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of...

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Crosses Below 200 Day Moving Average of $3.09

PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization PR Newswire BOSTON, Oct...

PhaseV Raises $15 Million to Push the Boundaries of ML for Clinical Trial Optimization

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP  Get Free Report)s share price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day...

Oramed Pharmaceuticals (NASDAQ:ORMP) Share Price Crosses Below 200 Day Moving Average of $3.11

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP  Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $3.10 and traded as...

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Crosses Below Two Hundred Day Moving Average of $3.10

PALO ALTO, Calif., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, Scilex or Company ), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (OTC: SRNEQ, Sorrento...

Scilex Holding Company Enters into Non-Binding Term Sheets for the Purchase of all of the Scilex Common Shares, Preferred Shares, and Warrants Currently Owned by Sorrento Therapeutics, Inc. and is Declared the New Successful Bidder

This is a signal that ORMP's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Oramed Pharmaceuticals (ORMP, $3.16) Stochastic Oscillator left the oversold zone on September 06, 2023

Oramed Pharmaceuticals (ORMP, $3.12) Stochastic Oscillator left the oversold zone on August 14, 2023

This indicator may be signaling ORMP's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Oramed Pharmaceuticals (ORMP, $3.45) entered Uptrend as Momentum indicator ascends above 0 level on Aug 02, 2023

For the last three days, A.I.dvisor has detected that ORMP's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong downtrend ahead for ORMP, and traders may view it as a Sell signal for the next month. Traders may consider ...

Oramed Pharmaceuticals (ORMP, $3.39) Aroon Indicator entered a Downtrend on July 31, 2023.

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses on the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.

Watchers	5,066
52-Wk Low	$1.67
52-Wk High	$13.73

Market Cap	$85.92M
Volume (M)	144,140.00
52-Wk High	$13.73
52-Wk Low	$1.67

ORMP Oramed Pharmaceuticals, Inc

About

Feed

News

Sentiment

Earnings

Fundamentals